The objective of the current study was to determine the bioequivalence between a generic formulation of abacavir and the innovator product.MATERIAL AND. 6. Weller S, Chen S, Borland J et al. Bioequivalence of a Dolutegravir, Abacavir and Lamivudine Fixed-Dose Combination Tablet and the Effect of Food. JAIDS. Abacavir (Trizivir). Lamivudina + 300 mg. Abacavir. 1 Concentración en líquido cefalorraquídeo. study design for testing bioequivalence: a case study. Therapeutic Category | ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|